The Smith-Kettlewell Eye Research Institute
- Assets
- $20.0m
- Revenue
- $5.9m
- Investments
- $16.0m
- Employees
- 0
- Location
- San Francisco, CA
- Founding
- 06/1966
- Data as of
- 12/2022
- EIN
- 94-6127237
Organization Overview
The Smith-Kettlewell Eye Research Institute is located in San Francisco, CA. The organization was established in 1966. According to its NTEE Classification (H41) the organization is classified as: Eye Diseases, Blindness & Vision Impairments Research, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Smith-Kettlewell Eye Research Institute is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Smith-Kettlewell Eye Research Institute generated $5.9m in total revenue. This represents a relatively dramatic decline in revenue. Over the past 6 years, the organization has seen revenues fall by an average of (5.9%) each year. All expenses for the organization totaled $7.2m during the year ending 12/2022. You can explore the organizations financials more deeply in the financial statements section below.
Form
990PF
Mission & Program ActivityExcerpts From the 990PF Filing
TAX YEAR
2022
Describe the Organization's Program Activity:
Part 3 - Line 4a
BASIC RESEARCH - BASIC SCIENTIFIC RESEARCH TO INCREASE THE UNDERSTANDING OF NORMAL VISION IN SUPPORT OF VISION DISORDERS.
CLINICAL - CLINICAL RESEARCH TO DEVELOP NEW DIAGNOSTIC PROCEDURES AND TREATMENTS FOR VISUAL AND OTHER SENSORY DISORDERS.
REHABILITATIVE ENGINEERING RESEARCH CENTER - ENGINEERING RESEARCH TO PRODUCE BETTER TECHNIQUES FOR AID AND REHABILITATION OF THE BLIND AND PARTIALLY SIGHTED.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
John Brabyn Ceo/executive Director | 32 | $280,000 | |
William Good Secretary/sr Scientist Clinical | 24 | $203,265 | |
Arvind Chandna Treasurer/sr Scientist Clinical | 40 | $122,907 | |
Corazon Devis Chief Operations Officer | 40 | $192,219 | |
Gunilla Haegerstrom-Portnoy Chairman Finance Committee | 8 | $0 | |
David Guyton Board Member | 2 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Fusion Security Solutions | 12/30/22 | $152,582 |
Elizabeth Warner | 12/30/22 | $59,625 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Contributions, Gifts, Grants & Similar | $3,845,466 |
| Interest on Savings | $0 |
| Dividends & Interest | $513,709 |
| Net Rental Income | $0 |
| Net Gain on Sale of Assets | $1,507,953 |
| Capital Gain Net Income | $1,507,953 |
| Net ST Capital Gain | $0 |
| Income Modifications | $0 |
| Profit on Inventory Sales | $0 |
| Other Income | $0 |
| Total Revenue | $5,867,128 |
| Statement of Expenses | |
|---|---|
| Compensation of officers, directors, trustees, etc | $798,391 |
| Other employee salaries and wages | $2,780,681 |
| Pension plans, employee benefits | $1,294,122 |
| Interest | $0 |
| Taxes | $0 |
| Depreciation | $387,808 |
| Occupancy | $173,734 |
| Travel, conferences, and meetings | $66,160 |
| Printing and publications | $0 |
| Other expenses | $832,641 |
| Total operating and administrative expenses | $7,220,081 |
| Contributions, gifts, grants paid | $0 |
| Total expenses and disbursements | $7,220,081 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $181,171 |
| Savings and temporary cash investments | $588,554 |
| Net Accounts receivable | $0 |
| Net Pledges Receivable | $0 |
| Grants receivable | $314,116 |
| Receivables from Officers, Directors, or Controlling Persons | $0 |
| Net other notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $124,832 |
| Net Investments - land, buildings, equipment | $0 |
| Investments—mortgage loans | $0 |
| Investments—other | $0 |
| Net Land, buildings, and equipment | $2,810,604 |
| Other assets | $0 |
| Total assets | $20,036,766 |
| Accounts payable and accrued expenses | $707,507 |
| Grants payable | $0 |
| Deferred revenue | $37,325 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Mortgages and other notes payable | $0 |
| Other liabilities | $3,695 |
| Total liabilities | $748,527 |